EU reserves 400 million doses of US-made virus vaccine

EU reserves 400 million doses of US-made virus vaccine

 

The European Union said Thursday (13 August) it had reserved up to 400 million doses of a potential new coronavirus vaccine being developed by US giant Johnson & Johnson.

 

Preliminary talks concluded Friday for a first purchase of 200 million doses followed by an equal number later, a statement said.

 

“The envisaged contract with Johnson & Johnson would provide for the possibility for all EU Member States to purchase the vaccine, as well as to donate to lower and middle income countries,” it said.

 

 

ALSO READ: Coronavirus: Fear over rise in animal-to-human diseases

 

 

The bloc said it was in “intensive discussions” with other manufacturers for potential vaccines.

 

According to the World Health Organization, nearly 3.7 million cases of COVID-19 have been recorded in Europe; since the start of the pandemic, and 218,383 deaths.

 

On 31 July, the European Commission said it had reserved 300 million doses of another

potential vaccine being developed by French firm Sanofi.

 

“Our citizens’ lives and our economy need a safe and effective vaccine against the coronavirus. Today’s talks bring us closer to achieving this,” European Commission president Ursula von der Leyen said.

 

The EU is using about €2 billion from an emergency fund to strike advance purchase deals; with several vaccine makers in a bid to secure enough shots for its population of 450 million.

 

 

 

 

 

 

 

Source: Euractiv

About The Author

Osigweh Lilian Oluchi is a graduate of the University of Lagos where she obtained a B.A (Hons) in English, Masters in Public and International affairs (MPIA). Currently works with 1stnews as a Database Manager / Writer. [email protected]

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *